ARANTXA
ISLA RUIZ
Instituto de Investigación Sanitaria Bioaraba
Gasteiz, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Bioaraba (10)
2024
2023
-
Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study
Blood Purification, Vol. 52, Núm. 5, pp. 464-473
-
Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?
Pharmaceutics, Vol. 15, Núm. 4
2022
-
Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability
Antibiotics, Vol. 11, Núm. 5
-
Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study
Journal of Intensive Care, Vol. 10, Núm. 1
2021
-
Pharmacokinetic/pharmacodynamic evaluation of the antimicrobial therapy of pneumococcal invasive disease in adults in post-PCV13 vaccine period in Madrid, Spain
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 10, pp. 2145-2152
-
Pharmacotherapeutic management of Parkinson's disease inpatients: How about asking hospital pharmacists?
European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E140-E145
-
Population pharmacokinetics of levetiracetam and dosing evaluation in critically ill patients with normal or augmented renal function
Pharmaceutics, Vol. 13, Núm. 10
-
Pseudomonas aeruginosa susceptibility in spain: Antimicrobial activity and resistance suppression evaluation by pk/pd analysis
Pharmaceutics, Vol. 13, Núm. 11
-
Quantification of ceftaroline in human plasma using high‐performance liquid chromatography with ultraviolet detection: Application to pharmacokinetic studies
Pharmaceutics, Vol. 13, Núm. 7